ArticleBMC cancer2022

Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7 years receiving cancer treatments.

Deborah Tomlinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.